The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

futibatinib

15th Nov 2024

Plain language summary: safety analysis of futibatinib across different cancer types

30th Jul 2024

futibatinib

Plain language summary: safety analysis of futibatinib across different cancer types

Plain language summary of the FOENIX-CCA2 study: Futibatinib for advanced bile duct cancer